Lack of caspase 8 directs neuronal progenitor-like reprogramming and small cell lung cancer progression

caspase 8 的缺失导致神经元祖细胞样重编程和小细胞肺癌进展。

阅读:3
作者:Ariadne Androulidaki,Fanyu Liu,Christina M Bebber,Ilmars Kisis,Vignesh Sakthivelu,Pascal Hunold,Lioba Koerner,Alina Dahlhaus,Fatma Isil Yapici,Christina Grimm,Alicja Pacholewska,Sofya Tishina,Franka Doskotz,Lucia A Torres Fernández,Jenny Stroh,Ali T Abdallah ,Julia Beck,Lejla Mulalic,Anna Schmitt,Holger Grüll,Thorsten Persigehl,Alexander Quaas,Martin Peifer,Johannes Brägelmann ,H Christian Reinhardt,Pascal Nieper,Robert Hänsel-Hertsch,Roman K Thomas,Julie George,Michal R Schweiger,Manolis Pasparakis ,Filippo Beleggia ,Silvia von Karstedt

Abstract

Most neuroendocrine cancers lack caspase 8 protein expression. While this feature was thought to facilitate escape from extrinsic apoptosis, its cancer-regulatory function has remained unexplored. Here, we devise a mouse model of small cell lung cancer (SCLC) recapitulating the lack of expression of caspase 8 seen in humans and uncover an unexpected role for necroptosis-fueled pre-tumoral inflammation resulting in reprogramming towards a neuronal progenitor cell-like state and increased metastatic disease. Notably, transcriptional signatures of this cellular state are enriched in relapsed and metastatic human SCLC. Mechanistically, caspase 8 loss within the pre-tumoral niche promotes inflammation marked by increased recruitment of regulatory T cells (Tregs) which are responsible for the promotion of metastatic disease. Importantly, inactivation of the necroptosis executioner MLKL reverses pre-tumoral inflammation, decreases metastasis as well as neuronal-like reprogramming. Taken together, our findings suggest that pre-tumoral inflammatory cell death contributes to neuronal progenitor mimicry, immunosuppression and increased metastasis in SCLC.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。